Allegra is an antihistamine in the form of tablet. It is also known as second-generation antihistamine that reduces the effects of natural chemical histamine in the body. This natural chemical histamine can lead to allergies with symptoms like sneezing, itching, watery eyes, and runny nose.
Allegra does not cause sedation and is approved by the Federal Aviation Administration (FAA) for use by pilots.
Allergra is composed of fexofenadine hydrochloride molecule, that blocks the action of histamine at the H1 receptor (signal receptors in neurons), helping to relieve allergic reactions.
Fexofenadine helps in relieving symptoms associated with seasonal and year-round allergies including sneezing, itchy palate, runny nose, and itchy, tearing, and redness of the eyes. It is also used to relieve the symptoms associated with an allergic skin reaction (chronic idiopathic urticaria) including hives and itchy skin
Allegra is manufactured by Sanofi Limited . Sanofi was incorporated in May 1956 and is one of the world’s leading pharmaceutical companies. It has 79 manufacturing sites in 36 countries
Your doctor may have prescribed Allegra because you could be suffering from Allergic reactions and symptoms.
Allegra is an orally available medication that contains the active substance Fexofenadine which blocks the action of the body’s natural chemical histamine which is responsible for many of the symptoms caused by an allergy. It has to be taken as directed by your physician in the right doses.
Allergic symptoms are caused by your immune system due to various allergens that may trigger an allergic reaction. Allergies are dependant on your genes and can vary from person to person.
Allergic reactions happen when the immune system recognises an allergen and the cells release histamines which causes inflammation in that region. This prompts the immune system to respond to the inflammation and start deep repair.
“A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis”. Clin Ther. 31 (5): 921–44. doi:10.1016/j.clinthera.2009.05.017. PMID 19539095.
If you are a healthcare practitioner and want additional material on the brand, disease, or molecule we have a few articles that can be hand-delivered by the company representative to you directly.